Home / NEWS / Top News / Biogen’s new Alzheimer’s drug could cost Medicare billions of dollars a year, report finds

Biogen’s new Alzheimer’s drug could cost Medicare billions of dollars a year, report finds

Biogen’s new Alzheimer’s soporific, Aduhelm, could cost Medicare billions of dollars a year, according to an analysis by the nonprofit Kaiser Family Institution.

Check Also

Ponzi schemer Madoff earned $710 for almost 3,000 hours of prison work, got ‘not very dependable’ review

Bernie Madoff decreased in prison, where he was serving a 150-year sentence for running the …

Leave a Reply

Your email address will not be published. Required fields are marked *